[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(11/06, FRI) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)

 바이오엔텍, 로슈 공동개발 '신항원 암백신'서 "발 빼" 
[https://www.biospectator.com/news/view/30306](https://www.biospectator.com/news/view/30306)

 씨어스, 3Q 영업이익 적자전환 "서버 수급차질 영향" 
[https://www.biospectator.com/news/view/30324](https://www.biospectator.com/news/view/30324)

 에이비스, ‘디지털병리 IMS’ 식약처 “제조신고 완료”
[https://www.biospectator.com/news/view/30318](https://www.biospectator.com/news/view/30318)

 루닛, 의료특화 파운데이션 모델 '러닝유닛 2.0' 공개
[https://www.biospectator.com/news/view/30323](https://www.biospectator.com/news/view/30323)

 SK바이오팜, ‘AI 특화 파운데이션 모델’ 성과 발표
[https://www.biospectator.com/news/view/30325](https://www.biospectator.com/news/view/30325)

 애브비, 日넥세라 우선순위↓ ‘EP4 작용제’ 14.7억弗 딜
[https://www.biospectator.com/news/view/30311](https://www.biospectator.com/news/view/30311)

 큐리언트, 'Axl/Mer/CSF1R' cGvHD 1b상 "ORR 33%
[https://www.biospectator.com/news/view/30307](https://www.biospectator.com/news/view/30307)

 SK바이오사이언스, 3Q 매출 1824억 "전년比 21%↑" 
[https://www.biospectator.com/news/view/30329](https://www.biospectator.com/news/view/30329)

 동아 메타비아, 'GLP-1/GCG' 비만1상 "간지방 68%↓"
[https://www.biospectator.com/news/view/30326](https://www.biospectator.com/news/view/30326)

 인벤테라, LG화학과 '췌담관 MRI 조영제' API 공급계약
[https://www.biospectator.com/news/view/30330](https://www.biospectator.com/news/view/30330)

 세르비에, '26.5억弗 L/I' 미오신저해제 근육질환 “실패”
[https://www.biospectator.com/news/view/30312](https://www.biospectator.com/news/view/30312)

 머크, 한미 'GLP/GCG' MASH 2상 "1차 충족..섬유화 강점"
[https://www.biospectator.com/news/view/30321](https://www.biospectator.com/news/view/30321)

 한미약품, ‘에피데이’ 런칭..투약·식사·운동관리 비만앱
[https://www.biospectator.com/news/view/30334](https://www.biospectator.com/news/view/30334)

 제노스코, 'ROCK2 저해제' 1상 완료 "본격 적응증 확대" 
[https://www.biospectator.com/news/view/30322](https://www.biospectator.com/news/view/30322)

[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(11/06, FRI) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)